{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:21:23Z","timestamp":1794345683363,"version":"4.9.0"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP. 2 \/244\/45"],"award-info":[{"award-number":["RGP. 2 \/244\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>DENV NS2B-NS3 protease inhibitors were designed based upon the\nreference molecule, 4-(1,3-dioxoisoindolin-2-yl)-N-(4-ethylphenyl) benzenesulfonamide, reported\nby our team with the aim to optimize lead compound via rational approach. Top five best\nscoring molecules with zinc ids ZINC23504872, ZINC48412318, ZINC00413269,\nZINC13998032 and ZINC75249613 bearing \u2018pyrimidin-4(3H)-one\u2019 basic scaffold have been\nidentified as a promising candidate against DENV protease enzyme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The shape and electrostatic complementary between identified HITs and reference\nmolecules were found to be Tanimotoshape 0.453, 0.690, 0.680, 0.685 &amp; 0.672 respectively and\nTanimotoelectrostatic 0.211, 0.211, 0.441, 0.442, 0.442 and 0.442 respectively. The molecular\ndocking studies suggested that the identified HITs displayed the good interactions with active\nsite residues and lower binding energies. The stability of docked complexes was assessed by\nMD simulations studies. The RMSD values of protein backbone (1.6779, 3.1563, 3.3634,\n3.3893 &amp; 3.0960 \u00c5) and protein backbone RMSF values (1.0126, 1.0834, 1.0890, 0.9974 &amp;\n1.0080 \u00c5 respectively) for all top five HITs were stable and molecules did not fluctuate from\nthe active pocket during entire 100ns MD run.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The druggability Dscore below 1 indicate the tightly binding of ligand at the active\nsite. Dscore for ZINC23504872 was found to be 1.084 while for the second class of compounds\nZINC48412318, ZINC00413269, ZINC13998032 and ZINC75249613, 0.503, 0.484, 0.487\nand 0.501 Dscores were observed. In-silico ADMET calculations suggested that all five\nHITs were possessed the drug likeliness properties and did not violate the Lipinski\u2019s rule\nof five.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Summing up, these in-silico generated data suggested that the identified molecules\nbearing pyrimidin-4(3H)-one would be promising scaffold for DENV protease inhibitors.\nHowever, experimental results are needed to prove the obtained results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099329789240905141013","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T02:30:48Z","timestamp":1730255448000},"page":"43-60","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying Novel Inhibitors for Dengue NS2B-NS3 Protease by Combining Topological similarity, Molecular Dynamics, MMGBSA and SiteMap Analysis"],"prefix":"10.2174","volume":"22","author":[{"given":"Sheikh","family":"Murtuja","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Health and Medical Sciences Adamas University, Kolkata, 700126, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-1771","authenticated-orcid":true,"given":"Mohd Usman Mohd","family":"Siddique","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Pratyush","family":"Shrivastava","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeeta O","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Wagh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azim","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Sayeed","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus,Aurangabad, 431001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Saquib","family":"Hasnain","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Palamau Institute of Pharmacy,Chianki, Daltonganj, 822102, Jharkhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer N","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shri Vile Parle Kelavani Mandal\u2019sInstitute of Pharmacy, Dhule, 424001, (MH), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"Bhatt S.","year":"2013","unstructured":"Bhatt S.; Gething P.W.; Brady O.J.; Messina J.P.; Farlow A.W.; Moyes C.L.; Drake J.M.; Brownstein J.S.; Hoen A.G.; Sankoh O.; Myers M.F.; George D.B.; Jaenisch T.; Wint G.R.W.; Simmons C.P.; Scott T.W.; Farrar J.J.; Hay S.I.; The global distribution and burden of dengue. Nature  2013,496(7446),504-507","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"Guzman M.G.","year":"2010","unstructured":"Guzman M.G.; Halstead S.B.; Artsob H.; Buchy P.; Farrar J.; Gubler D.J.; Hunsperger E.; Kroeger A.; Margolis H.S.; Mart\u00ednez E.; Nathan M.B.; Pelegrino J.L.; Simmons C.; Yoksan S.; Peeling R.W.; Dengue: a continuing global threat. Nat Rev Microbiol  2010,8(S12),S7-S16","journal-title":"Nat Rev Microbiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0022-3476(97)70054-4","volume":"131","author":"Kautner I.","year":"1997","unstructured":"Kautner I.; Robinson M.J.; Kuhnle U.; Dengue virus infection: Epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention. J Pediatr  1997,131(4),516-524","journal-title":"J Pediatr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"Simmons C.P.","year":"2012","unstructured":"Simmons C.P.; Farrar J.J.; van Vinh Chau N.; Wills B.; Dengue. N Engl J Med  2012,366(15),1423-1432","journal-title":"N Engl J Med"},{"key":"ref=5","year":"2021","unstructured":"Dengue and severe dengue.  Available from:  https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue2021"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/14760584.2017.1335201","volume":"16","author":"Guy B.","year":"2017","unstructured":"Guy B.; Noriega F.; Ochiai R.L.; L\u2019azou M.; Delore V.; Skipetrova A.; Verdier F.; Coudeville L.; Savarino S.; Jackson N.; A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev Vaccines  2017,16(7),671-684","journal-title":"Expert Rev Vaccines"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0042-6822(89)90639-9","volume":"171","author":"Bazan J.F.","year":"1989","unstructured":"Bazan J.F.; Fletterick R.J.; Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses. Virology  1989,171(2),637-639","journal-title":"Virology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1128\/jvi.65.11.6042-6050.1991","volume":"65","author":"Chambers T.J.","year":"1991","unstructured":"Chambers T.J.; Grakoui A.; Rice C.M.; Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol  1991,65(11),6042-6050","journal-title":"J Virol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","volume":"65","author":"Falgout B.","year":"1991","unstructured":"Falgout B.; Pethel M.; Zhang Y.M.; Lai C.J.; Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol  1991,65(5),2467-2475","journal-title":"J Virol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/BSR20100142","volume":"31","author":"Phong W.Y.","year":"2011","unstructured":"Phong W.Y.; Moreland N.J.; Lim S.P.; Wen D.; Paradkar P.N.; Vasudevan S.G.; Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target. Biosci Rep  2011,31(5),399-409","journal-title":"Biosci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","volume":"33","author":"De Clercq E.","year":"2009","unstructured":"De Clercq E.; Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents  2009,33(4),307-320","journal-title":"Int J Antimicrob Agents"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/infdis\/jis761","volume":"207","author":"Wyles D.L.","year":"2013","unstructured":"Wyles D.L.; Antiviral resistance and the future landscape of hepatitis C virus infection therapy. J Infect Dis  2013,207,S33-S39","journal-title":"J Infect Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2016.04.008","volume":"117","author":"Timiri A.K.","year":"2016","unstructured":"Timiri A.K.; Sinha B.N.; Jayaprakash V.; Progress and prospects on DENV protease inhibitors. Eur J Med Chem  2016,117,125-143","journal-title":"Eur J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"116415","DOI":"10.1016\/j.bmc.2021.116415","volume":"49","author":"Murtuja S.","year":"2021","unstructured":"Murtuja S.; Shilkar D.; Sarkar B.; Sinha B.N.; Jayaprakash V.; A short survey of dengue protease inhibitor development in the past 6 years (2015\u20132020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases. Bioorg Med Chem  2021,49,116415","journal-title":"Bioorg Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.sbi.2018.01.006","volume":"49","author":"Colwell L.J.","year":"2018","unstructured":"Colwell L.J.; Statistical and machine learning approaches to predicting protein\u2013ligand interactions. Curr Opin Struct Biol  2018,49,123-128","journal-title":"Curr Opin Struct Biol"},{"key":"ref=16","first-page":"2459","volume":"24","author":"Heck G.S.","year":"2017","unstructured":"Heck G.S.; Pintro V.O.; Pereira R.R.; Mb Levin N.; Supervised machine learning methods applied to predict ligand- binding affinity. Curr Med Chem  2017,24,2459-2470","journal-title":"Curr Med Chem"},{"key":"ref=17","first-page":"4321","volume":"23","author":"Luo Y.","year":"2017","unstructured":"Luo Y.; Wang L.; Discovery and development of atp-competitive mtor inhibitors using computational approaches. Curr Pharm Des  2017,23(29),4321-4331","journal-title":"Curr Pharm Des"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/138620711797537102","volume":"14","author":"Badrinarayan P.","year":"2011","unstructured":"Badrinarayan P.; Narahari Sastry G.; Virtual high throughput screening in new lead identification. Comb Chem High Throughput Screen  2011,14(10),840-860","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5530\/ijper.52.1.18","volume":"52","author":"Siddique M.U.","year":"2018","unstructured":"Siddique M.U.; Sinha B.N.; Jayaprakash V.; Comparative shape and electrostatic study of highly potent and selective CYP1B1 inhibitor: assessment of active site of CYP1B1 by binding mode analysis using site map tool. Indian J Pharmaceut Educ Res  2018,52(1),159-165","journal-title":"Indian J Pharmaceut Educ Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.genrep.2018.10.011","volume":"13","author":"Usman M.S.","year":"2018","unstructured":"Usman M.S.; Bharbhuiya T.K.; Mondal S.; Rani S.; Kyal C.; Kumari R.;  Gene Rep  2018,13,212-219","journal-title":"Gene Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7546\/ijba.2020.24.3.000537","volume":"24","author":"Siddique M.U.","year":"2020","unstructured":"Siddique M.U.; Ansari A.; Sinha B.N.; Jayaprakash V.; Comparative computational studies on selective cytochromep450 1b1 inhibitors. Int J Bioauto  2020,24(3),213-224","journal-title":"Int J Bioauto"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14805\/jphchem.2017.art92","volume":"4","author":"Bagchi S.","year":"2017","unstructured":"Bagchi S.; Alia U.; Mohammad F.; Mohd Siddique M.U.; High throughput virtual screening based discovery of dengue protease inhibitor. J Pharmaceu Chem  2017,4(3),35-40","journal-title":"J Pharmaceu Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/jm301818g","volume":"56","author":"Bostr\u00f6m J.","year":"2013","unstructured":"Bostr\u00f6m J.; Grant J.A.; Fjellstr\u00f6m O.; Thelin A.; Gustafsson D.; Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid. J Med Chem  2013,56(8),3273-3280","journal-title":"J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/ct300117j","volume":"8","author":"Bakan A.","year":"2012","unstructured":"Bakan A.; Nevins N.; Lakdawala A.S.; Bahar I.; Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules. J Chem Theory Comput  2012,8(7),2435-2447","journal-title":"J Chem Theory Comput"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","volume":"62","author":"Timiri A.K.","year":"2015","unstructured":"Timiri A.K.; Selvarasu S.; Kesherwani M.; Vijayan V.; Sinha B.N.; Devadasan V.; Jayaprakash V.; Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. Bioorg Chem  2015,62,74-82","journal-title":"Bioorg Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model  2005,45(1),177-182","journal-title":"J Chem Inf Model"},{"key":"ref=27","year":"2018","unstructured":"Schr\u00f6dinger Release 2018: LigPrep, Schr\u00f6dinger, LLC, New York, NY,  2018"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"Sastry G.M.","year":"2013","unstructured":"Sastry G.M.; Adzhigirey M.; Day T.; Annabhimoju R.; Sherman W.; Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mol Des  2013,27(3),221-234","journal-title":"J Comput Aid Mol Des"},{"key":"ref=29","year":"2018","unstructured":"Schr\u00f6dinger Release 2018: Schr\u00f6dinger, LLC, New York, NY,  2018"},{"key":"ref=30","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2020.1852968","volume":"40","author":"Dhankhar P.","year":"2022","unstructured":"Dhankhar P.; Dalal V.; Singh V.; Tomar S.; Kumar P; Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2. J Biomol Struc Dynam  2022,40(9)","journal-title":"J Biomol Struc Dynam"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e202201728","DOI":"10.1002\/slct.202201728","volume":"7","author":"Dalal V.","year":"2022","unstructured":"Dalal V.; Kumari R.; Screening and identification of natural product\u2010like compounds as potential antibacterial agents targeting FemC of staphylococcus aureus: an in\u2010silico approach. ChemistrySelect  2022,7(42),e202201728","journal-title":"ChemistrySelect"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"Lipinski C.A.","year":"2004","unstructured":"Lipinski C.A.; Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol  2004,1(4),337-341","journal-title":"Drug Discov Today Technol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1021\/ci2002704","volume":"51","author":"Sastry G.M.","year":"2011","unstructured":"Sastry G.M.; Dixon S.L.; Sherman W.; Rapid shape-based ligand alignment and virtual screening method based on atom\/feature-pair similarities and volume overlap scoring. J Chem Inf Model  2011,51(10),2455-2466","journal-title":"J Chem Inf Model"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bpc.2018.05.010","volume":"240","author":"Bitencourt-Ferreira G.","year":"2018","unstructured":"Bitencourt-Ferreira G.; De Azevedo W.F.; Development of a machine-learning model to predict Gibbs free energy of binding for protein-ligand complexes. Biophys Chem  2018,240,63-69","journal-title":"Biophys Chem"},{"key":"ref=35","first-page":"801","volume":"19","author":"Morrone Xavier M.","year":"2016","unstructured":"Morrone Xavier M.; Sehnem Heck G.; Boff de Avila M.; Maria Bernhardt Levin N.; Oliveira Pintro V.; Lemes Carvalho N.; Filgueira de Azevedo W.; Computational tool for statistical analysis of docking results and development of scoring functions. Comb Chem High Throughput Screen  2016,19,801-812","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"13419","DOI":"10.1021\/jp074285e","volume":"111","author":"Radhakrishnan M.L.","year":"2007","unstructured":"Radhakrishnan M.L.; Tidor B.; Specificity in molecular design: a physical framework for probing the determinants of binding specificity and promiscuity in a biological environment. J Phys Chem B  2007,111(47),13419-13435","journal-title":"J Phys Chem B"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The Protein Data Bank. Nucleic Acids Res  2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"Halgren T.A.","year":"2009","unstructured":"Halgren T.A.; Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model  2009,49(2),377-389","journal-title":"J Chem Inf Model"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"Halgren T.","year":"2007","unstructured":"Halgren T.; New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des  2007,69(2),146-148","journal-title":"Chem Biol Drug Des"},{"key":"ref=40","author":"Schr\u00f6dinger L.L.C.","year":"2020","unstructured":"Schr\u00f6dinger L.L.C.;  DE Shaw Research  2020","journal-title":"DE Shaw Research"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"Mark P.","year":"2001","unstructured":"Mark P.; Nilsson L.; Structure and dynamics of the tip3p, spc, and spc\/e water models at 298 K. J Phys Chem A  2001,105(43),9954-9960","journal-title":"J Phys Chem A"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"Jorgensen W.L.","year":"1996","unstructured":"Jorgensen W.L.; Maxwell D.S.; Tirado-Rives J.; Development and testing of the opls all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc  1996,118(45),11225-11236","journal-title":"J Am Chem Soc"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"13429","DOI":"10.1021\/j100153a002","volume":"97","author":"Gibson D.A.","year":"1993","unstructured":"Gibson D.A.; Carter E.A.; Time-reversible multiple time scale ab initio molecular dynamics. J Phys Chem  1993,97(51),13429-13434","journal-title":"J Phys Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1021\/jp951968y","volume":"100","author":"Cheng A.","year":"1996","unstructured":"Cheng A.; Merz K.M.; Application of the nose-hoover chain algorithm to the study of protein dynamics. J Phys Chem  1996,100(5),1927-1937","journal-title":"J Phys Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/0026897021000044025","volume":"101","author":"Kalibaeva G.","year":"2003","unstructured":"Kalibaeva G.; Ferrario M.; Ciccotti G.; Constant pressure-constant temperature molecular dynamics: a correct constrained NPT ensemble using the molecular virial. Mol Phys  2003,101(6),765-778","journal-title":"Mol Phys"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099329789240905141013","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/235838\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099329789240905141013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:25:13Z","timestamp":1770355513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/235838\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099329789240905141013","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}